m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis
Open Access
- 7 January 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1664788
Abstract
Background: Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) are life-threatening complications that often arise after CAR T-cell immunotherapy. Endothelial dysfunction is believed to play a central role in their development, leading to the interest in biomarker-based tools for diagnosis and differentiating these toxicities from sepsis. This study aimed to evaluate the Endothelial Activation Stress Index (EASIX) and its modified version (m-EASIX, which replaces creatinine with C-reactive protein [CRP] (mg/dL)) as early predictors of severe CRS and ICANS, as well as tools to distinguish CRS from sepsis. Methods: One hundred and nineteen patients treated with CAR T-cell therapy for CD19-positive hematologic malignancies (n=94) or multiple myeloma (n=23) were included. EASIX and m-EASIX scores were measured at various time points: before CAR T-cell infusion, 24–48 hours post-infusion, at CRS or ICANS onset, and after treatment for each toxicity. A comparator group of 129 sepsis patients, including 86 with hematologic malignancies, was also analyzed. Results: Both EASIX and m-EASIX correlated with biomarkers of endotheliopathy, with m-EASIX showing stronger predictive power for severe toxicities and ICU admission. Higher EASIX and m-EASIX values at early time points were associated with worse overall survival (OS). Furthermore, m-EASIX accurately distinguished CRS from sepsis at symptom onset. Conclusions: m-EASIX is a practical and accessible tool for the early prediction of severe CAR T-cell-related toxicities, risk stratification, and differential diagnosis from sepsis, offering potential to guide clinical decision-making and early intervention.Keywords
This publication has 54 references indexed in Scilit:
- Endothelial activation and stress index (EASIX) in coronary artery disease: a simplified measure as a promising biomarkerClinical Research in Cardiology, 2024
- Modified EASIX scores predict severe CRS/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapyAnnals of Hematology, 2024
- IL-10 plus the EASIX score predict bleeding events after anti-CD19 CAR T-cell therapyAnnals of Hematology, 2023
- Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantationIntensive Care Medicine, 2023
- Pre-transplant EASIX and sepsis after allogeneic stem cell transplantationIntensive Care Medicine, 2022
- Managing the toxicities of CAR T‐cell therapyHematological Oncology, 2019
- Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathyAnnals of Hematology, 2019
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndromePediatric Nephrology, 2015
- C‐reactive protein impairs human CD14+ monocyte‐derived dendritic cell differentiation, maturation and functionEuropean Journal of Immunology, 2006